Close

Rating History for Sarepta Therapeutics (SRPT) by Piper Sandler

More Stocks Rated by Piper Sandler | Latest Ratings for SRPT
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/2/2021 Danielle Brill Maintain Overweight
(N/A)		 130.00
(140.00)		  
 		   Details